| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Answer to: “Histogram and Vertical Bar Diagram: Often Misapprehended Concept” by M. Lakshmanan
|
Du, Jie
|
|
2014
|
28 |
4 |
p. 389
|
artikel
|
| 2 |
Azilsartan Decreases Renal and Cardiovascular Injury in the Spontaneously Hypertensive Obese Rat
|
Khan, Md. Abdul Hye
|
|
2014
|
28 |
4 |
p. 313-322
|
artikel
|
| 3 |
Biodegradable Polymer Drug-Eluting Stents Versus Second-Generation Drug-Eluting Stents for Patients With Coronary Artery Disease: An Update Meta-Analysis
|
Wang, Yanyu
|
|
2014
|
28 |
4 |
p. 379-385
|
artikel
|
| 4 |
Capsaicin-Induced Cardioprotection. Is Hypothermia or the Salvage Kinase Pathway Involved?
|
Dow, Joan
|
|
2014
|
28 |
4 |
p. 295-301
|
artikel
|
| 5 |
Clinical Benefits of Azilsartan Beyond Blood Pressure Lowering?
|
Kajiya, Takashi
|
|
2014
|
28 |
4 |
p. 293-294
|
artikel
|
| 6 |
Histogram and Vertical Bar diagram: Often Misapprehended Concept
|
Lakshmanan, Mageshwaran
|
|
2014
|
28 |
4 |
p. 387
|
artikel
|
| 7 |
Laboratory Aspirin Resistance Reversibility in Diabetic Patients: a Pilot Study Using Different Pharmaceutical Formulations
|
Grimaldi, Roberto
|
|
2014
|
28 |
4 |
p. 323-329
|
artikel
|
| 8 |
Lipid-lowering Therapies, Glucose Control and Incident Diabetes: Evidence, Mechanisms and Clinical Implications
|
Zafrir, Barak
|
|
2014
|
28 |
4 |
p. 361-377
|
artikel
|
| 9 |
MiR-132 Inhibits Expression of SIRT1 and Induces Pro-inflammatory Processes of Vascular Endothelial Inflammation through Blockade of the SREBP-1c Metabolic Pathway
|
Zhang, Liwei
|
|
2014
|
28 |
4 |
p. 303-311
|
artikel
|
| 10 |
NLRP3, a Potential Therapeutic Target for Type 2 Diabetes?
|
Liu, Shan-Shan
|
|
2014
|
28 |
4 |
p. 391-392
|
artikel
|
| 11 |
Renin-Angiotensin System Phenotyping as a Guidance Toward Personalized Medicine for ACE Inhibitors: can the Response to ACE Inhibition be Predicted on the Basis of Plasma Renin or ACE?
|
Schilders, Joyce E.M.
|
|
2014
|
28 |
4 |
p. 335-345
|
artikel
|
| 12 |
Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors: New among Antidiabetic Drugs
|
Opie, L. H.
|
|
2014
|
28 |
4 |
p. 331-334
|
artikel
|
| 13 |
Thioredoxin-Interacting Protein: Pathophysiology and Emerging Pharmacotherapeutics in Cardiovascular Disease and Diabetes
|
Chong, Cher-Rin
|
|
2014
|
28 |
4 |
p. 347-360
|
artikel
|
Tijdschrift beschrijving